Please join us at London Museum Spaces for the official UK launch of the £7.5m Longitude Prize on ALS - a global initiative to incentivise the use of AI to transform drug discovery for the treatment of ALS (the most common form of MND or motor neuron disease).
The five year challenge prize programme will engage disease experts and data scientists worldwide to identify and validate drug targets: specific molecules in the body linked to ALS that can then be targeted with a new or repurposed drug. This will not only drive understanding of ALS, but help to accelerate the discovery of new drug treatments in the future.
To power these discoveries, the Longitude Prize on ALS has brought together multiple global data partners to provide participants with access to a wealth of ALS patient data at an unprecedented scale to advance their breakthroughs.
Confirmed so far as speakers are:
- Lord Martin Rees, Astronomer Royal & Chair of the Longitude Prize Committee
- Lucy Hawking, journalist and daughter of MND Association’s late Patron, Prof. Stephen Hawking
- Tris Dyson, MD of Challenge Works
- Prof. Ammar Al-Chalabi, Professor of Neurology and Complex Disease Genetics & co-Director of the UK MND Research Institute
- Dr. Usman Khan, Trustee at the Motor Neurone Disease Association
Don't miss this opportunity to be part of the future of medicine!